Literature DB >> 29575788

Acute Kidney Injury in Critically Ill Patients: A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous Renal Replacement Therapy.

Abdullah Al-Hwiesh1, Ibrahiem Abdul-Rahman1, Fredric Finkelstein2, Jose Divino-Filho3, Hatem Qutub1, Nadia Al-Audah1, Abdalla Abdelrahman4, Nazeeh El-Fakhrany1, Mohammed Nasr El-Din1, Tamer El-Salamony1, Abdulsalam Noor1, Mohammed Al-Shahrani1, Khalid Al-Otaibi1.   

Abstract

Few studies have discussed the role of peritoneal dialysis (PD) in managing acute kidney injury (AKI) in critically ill patients. The present study compares the outcome of AKI in intensive care unit (ICU) patients randomized to treatment with tidal PD (TPD) or continuous venovenous hemodiafiltration (CVVHDF). One hundred and twenty-five ICU patients with AKI were randomly allotted to CVVHDF, (Group A, N = 62) or TPD, (group B, N = 63). Cause and severity of renal injury were assessed at the time of initiating dialysis. The primary outcome was hospital mortality at 28 days, and secondary outcomes were time to recovery of renal function, duration of stay in the ICU, metabolic and fluid control, and improvement of sensorial and hemodynamic parameters. No statistically significant differences were observed between groups in regard to patients' characteristics. The survival at 28 days was significantly better in the patients treated with TPD when compared to CVVHDF (69.8% vs. 46.8%, P < 0.01). Infectious complications were significantly less (P < 0.01) in the TPD group (9.5%) when compared to the CVVHDF group (17.7%). Recovery of kidney function (60.3% vs. 35.5%), median time to resolution of AKI and the median duration of ICU stay of 9 days (7-11) vs. 19 days (13-20) were all in favor of TPD (P < 0.01). This study suggests that there are better outcomes with TPD compared to CRRT in the treatment of critically ill patients with AKI.
© 2018 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Entities:  

Keywords:  Acute kidney injury; Acute tubular necrosis; Continuous venovenous hemodiafiltration; Renal replacement therapy; Sepsis; Tidal peritoneal dialysis

Mesh:

Year:  2018        PMID: 29575788     DOI: 10.1111/1744-9987.12660

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  11 in total

1.  Peritoneal Dialysis for Acute Kidney Injury Treatment in the United States: Brought to You by the COVID-19 Pandemic.

Authors:  Vesh Srivatana; Vikram Aggarwal; Fredric O Finkelstein; Mihran Naljayan; John H Crabtree; Jeffrey Perl
Journal:  Kidney360       Date:  2020-04-24

2.  Acute Peritoneal Dialysis During the COVID-19 Pandemic at Bellevue Hospital in New York City.

Authors:  Nina J Caplin; Olga Zhdanova; Manish Tandon; Nathan Thompson; Dhwanil Patel; Qandeel Soomro; Fnu Ranjeeta; Leian Joseph; Jennifer Scherer; Shivam Joshi; Betty Dyal; Harminder Chawla; Sitalakshmi Iyer; Douglas Bails; Judith Benstein; David S Goldfarb; Bruce Gelb; Richard Amerling; David M Charytan
Journal:  Kidney360       Date:  2020-10-16

Review 3.  Peritoneal Dialysis as a Renal Replacement Therapy Modality for Patients with Acute Kidney Injury.

Authors:  Sana Farooq Khan
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

Review 4.  Renal replacement therapy for critically ill patients with COVID-19-associated acute kidney injury: A review of current knowledge.

Authors:  Rasha Samir Shemies; Eman Nagy; Dalia Younis; Hussein Sheashaa
Journal:  Ther Apher Dial       Date:  2021-08-27       Impact factor: 2.195

5.  Safety and Efficacy of Bedside Peritoneal Dialysis Catheter Placement in the COVID-19 Era: Initial Experience at a New York City Hospital.

Authors:  Mariana Vigiola Cruz; Omar Bellorin; Vesh Srivatana; Cheguevara Afaneh
Journal:  World J Surg       Date:  2020-08       Impact factor: 3.352

Review 6.  [COVID-19 and acute kidney injury in the intensive care unit].

Authors:  Jan-Hendrik B Hardenberg; Helena Stockmann; Kai-Uwe Eckardt; Kai M Schmidt-Ott
Journal:  Nephrologe       Date:  2020-12-22

Review 7.  [Innovations in peritoneal dialysis].

Authors:  R Hausinger; C Schmaderer; U Heemann; Q Bachmann
Journal:  Nephrologe       Date:  2021-11-12

Review 8.  Comparing Renal Replacement Therapy Modalities in Critically Ill Patients With Acute Kidney Injury: A Systematic Review and Network Meta-Analysis.

Authors:  Zhikang Ye; Ying Wang; Long Ge; Gordon H Guyatt; David Collister; Waleed Alhazzani; Sean M Bagshaw; Emilie P Belley-Cote; Fang Fang; Liangying Hou; Philipp Kolb; Francois Lamontagne; Simon Oczkowski; Lonnie Pyne; Christian Rabbat; Matt Scaum; Borna Tadayon Najafabadi; Wimonchat Tangamornsuksan; Ron Wald; Qi Wang; Michael Walsh; Liang Yao; Linan Zeng; Abdullah Mohammed Algarni; Rachel J Couban; Paul Elias Alexander; Bram Rochwerg
Journal:  Crit Care Explor       Date:  2021-05-12

9.  Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury.

Authors:  Daniela Ponce; André L Balbi; Jonathan B Durand; Gustavo Moretta; José C Divino-Filho
Journal:  Clin Kidney J       Date:  2020-06-30

10.  The advantages of peritoneal dialysis over hemodialysis during the COVID-19 pandemic.

Authors:  Tz-Heng Chen; Yu-Hua Wen; Chun-Fan Chen; Ann Charis Tan; Yung-Tai Chen; Fan-Yu Chen; Chih-Ching Lin
Journal:  Semin Dial       Date:  2020-07-16       Impact factor: 2.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.